GUJTHEMBSEGujarat Themis Biosyn Ltd· Pharmaceuticals & BiotechnologyHighNegative
Announced Thu, 2 Jul, 2026 · 08:17 IST

Indirect pledge on promoter holding in Gujarat Themis Biosyn

Pledge Above 50pctPromoter Below 50pctOwnership Changes View source PDFExplain this filing

GUJTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.1%Reaction day
₹396.90
prior close
₹395.75
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.9%-1.0% vs market
Pharmaceuticals peers, median of 164sector+0.0%-0.1% vs sector

On the reaction day the stock moved 1.0 pts less than Nifty Microcap 250 and 0.1 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.5
10m
+0.1
15m
+0.0
30m
+0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.1+0.9-1.0+0.0-0.1
Next day
-2.7+0.5-3.2+0.5-3.2
2d
-3.5+0.7-4.2+0.0-3.5
3d
-4.8+0.0-4.8-0.3-4.4
4d
-7.5-2.0-5.6-1.2-6.3
5d
-6.0-0.1-5.9-0.7-5.3
1w
-3.5+1.4-4.9+0.4-3.9
15d
-9.5-1.4-8.1-1.4-8.1
1m
-9.5+1.3-10.9-0.3-9.2
2m
+4.2+3.8+0.4+0.6+3.5
3m
-6.4+2.9-9.3+0.5-6.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 164Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

VIPL, holding 98.988% of PBGIL (which owns 47.02% of Gujarat Themis Biosyn), pledged 51% of PBGIL equity shares and gave a non-disposal undertaking on another 47.988% to CTL Trusteeship, acting as debenture trustee for debentures issued by OSS Software Solutions Labs. This creates an indirect encumbrance over Gujarat Themis Biosyn shares. No direct shares of the target were acquired or transferred.

Likely market impact

Indirect encumbrance on promoter-level shares signals leverage at the holding company. No direct change in target shareholding.